vs
Natural Grocers by Vitamin Cottage, Inc.（NGVC）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Natural Grocers by Vitamin Cottage, Inc.的季度营收约是Orthofix Medical Inc.的1.5倍（$335.6M vs $219.9M），Natural Grocers by Vitamin Cottage, Inc.净利率更高（3.4% vs -1.0%，领先4.4%），Orthofix Medical Inc.同比增速更快（2.0% vs 1.6%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $11.6M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.4%）
Natural Grocers by Vitamin Cottage, Inc.是美国本土的特色零售连锁企业，主营认证有机食品、膳食补充剂、天然个护及环保家居类产品，面向健康意识较强的消费群体，门店覆盖美国多州，执行严格品控标准，拒绝售卖含人工添加剂的商品。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
NGVC vs OFIX — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $335.6M | $219.9M |
| 净利润 | $11.3M | $-2.2M |
| 毛利率 | 29.5% | 71.1% |
| 营业利润率 | 4.4% | 0.2% |
| 净利率 | 3.4% | -1.0% |
| 营收同比 | 1.6% | 2.0% |
| 净利润同比 | 14.0% | 92.4% |
| 每股收益（稀释后） | $0.49 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $335.6M | $219.9M | ||
| Q3 25 | $336.1M | $205.6M | ||
| Q2 25 | $328.7M | $203.1M | ||
| Q1 25 | $335.8M | $193.6M | ||
| Q4 24 | $330.2M | $215.7M | ||
| Q3 24 | $322.7M | $196.6M | ||
| Q2 24 | $309.1M | $198.6M | ||
| Q1 24 | $308.1M | $188.6M |
| Q4 25 | $11.3M | $-2.2M | ||
| Q3 25 | $11.8M | $-22.8M | ||
| Q2 25 | $11.6M | $-14.1M | ||
| Q1 25 | $13.1M | $-53.1M | ||
| Q4 24 | $9.9M | $-29.1M | ||
| Q3 24 | $9.0M | $-27.4M | ||
| Q2 24 | $9.2M | $-33.4M | ||
| Q1 24 | $8.0M | $-36.0M |
| Q4 25 | 29.5% | 71.1% | ||
| Q3 25 | 29.5% | 72.2% | ||
| Q2 25 | 29.9% | 68.7% | ||
| Q1 25 | 30.3% | 62.8% | ||
| Q4 24 | 29.9% | 69.0% | ||
| Q3 24 | 29.6% | 68.7% | ||
| Q2 24 | 29.2% | 67.8% | ||
| Q1 24 | 29.3% | 67.5% |
| Q4 25 | 4.4% | 0.2% | ||
| Q3 25 | 4.6% | -8.3% | ||
| Q2 25 | 4.7% | -7.9% | ||
| Q1 25 | 5.2% | -25.2% | ||
| Q4 24 | 4.0% | -5.3% | ||
| Q3 24 | 3.7% | -9.6% | ||
| Q2 24 | 4.2% | -12.5% | ||
| Q1 24 | 3.7% | -15.6% |
| Q4 25 | 3.4% | -1.0% | ||
| Q3 25 | 3.5% | -11.1% | ||
| Q2 25 | 3.5% | -6.9% | ||
| Q1 25 | 3.9% | -27.4% | ||
| Q4 24 | 3.0% | -13.5% | ||
| Q3 24 | 2.8% | -13.9% | ||
| Q2 24 | 3.0% | -16.8% | ||
| Q1 24 | 2.6% | -19.1% |
| Q4 25 | $0.49 | $-0.05 | ||
| Q3 25 | $0.51 | $-0.57 | ||
| Q2 25 | $0.50 | $-0.36 | ||
| Q1 25 | $0.56 | $-1.35 | ||
| Q4 24 | $0.43 | $-0.76 | ||
| Q3 24 | $0.38 | $-0.71 | ||
| Q2 24 | $0.40 | $-0.88 | ||
| Q1 24 | $0.35 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.2M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $220.0M | $450.0M |
| 总资产 | $668.6M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $23.2M | $82.0M | ||
| Q3 25 | $17.1M | $62.9M | ||
| Q2 25 | $13.2M | $65.6M | ||
| Q1 25 | $21.2M | $58.0M | ||
| Q4 24 | $6.3M | $83.2M | ||
| Q3 24 | $8.9M | $30.1M | ||
| Q2 24 | $13.9M | $26.4M | ||
| Q1 24 | $11.0M | $27.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
| Q4 25 | $220.0M | $450.0M | ||
| Q3 25 | $212.4M | $442.5M | ||
| Q2 25 | $202.5M | $458.3M | ||
| Q1 25 | $193.0M | $458.3M | ||
| Q4 24 | $181.9M | $503.1M | ||
| Q3 24 | $174.3M | $525.9M | ||
| Q2 24 | $167.8M | $546.0M | ||
| Q1 24 | $160.0M | $570.3M |
| Q4 25 | $668.6M | $850.6M | ||
| Q3 25 | $670.5M | $832.6M | ||
| Q2 25 | $659.0M | $837.2M | ||
| Q1 25 | $664.6M | $823.1M | ||
| Q4 24 | $648.9M | $893.3M | ||
| Q3 24 | $655.5M | $867.9M | ||
| Q2 24 | $654.4M | $882.0M | ||
| Q1 24 | $656.6M | $906.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $16.8M |
| 自由现金流率自由现金流/营收 | 3.4% | 7.6% |
| 资本支出强度资本支出/营收 | 2.9% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.86× | — |
| 过去12个月自由现金流最近4个季度 | $42.6M | $-1.3M |
8季度趋势，按日历期对齐
| Q4 25 | $21.1M | $27.7M | ||
| Q3 25 | $15.6M | $12.4M | ||
| Q2 25 | $2.9M | $11.6M | ||
| Q1 25 | $34.1M | $-18.4M | ||
| Q4 24 | $2.7M | $23.7M | ||
| Q3 24 | $24.5M | $11.7M | ||
| Q2 24 | $12.4M | $9.0M | ||
| Q1 24 | $20.2M | $-18.6M |
| Q4 25 | $11.6M | $16.8M | ||
| Q3 25 | $7.5M | $2.5M | ||
| Q2 25 | $-4.2M | $4.5M | ||
| Q1 25 | $27.6M | $-25.1M | ||
| Q4 24 | $-6.9M | $15.2M | ||
| Q3 24 | $18.0M | $6.3M | ||
| Q2 24 | $3.6M | $-360.0K | ||
| Q1 24 | $9.8M | $-29.1M |
| Q4 25 | 3.4% | 7.6% | ||
| Q3 25 | 2.2% | 1.2% | ||
| Q2 25 | -1.3% | 2.2% | ||
| Q1 25 | 8.2% | -13.0% | ||
| Q4 24 | -2.1% | 7.0% | ||
| Q3 24 | 5.6% | 3.2% | ||
| Q2 24 | 1.2% | -0.2% | ||
| Q1 24 | 3.2% | -15.4% |
| Q4 25 | 2.9% | 4.9% | ||
| Q3 25 | 2.4% | 4.8% | ||
| Q2 25 | 2.2% | 3.5% | ||
| Q1 25 | 1.9% | 3.5% | ||
| Q4 24 | 2.9% | 4.0% | ||
| Q3 24 | 2.0% | 2.7% | ||
| Q2 24 | 2.9% | 4.7% | ||
| Q1 24 | 3.4% | 5.6% |
| Q4 25 | 1.86× | — | ||
| Q3 25 | 1.32× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 2.60× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 2.72× | — | ||
| Q2 24 | 1.35× | — | ||
| Q1 24 | 2.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
